Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Keytruda
Biotech
Pyxis' shares fall on lukewarm early ADC results in solid tumors
While one might expect a positive readout from a biotech’s lead asset to boost stock prices, Pyxis Oncology’s shares tell a different story.
Fraiser Kansteiner
Nov 21, 2024 2:30pm
Merck's LAG-3 combo fails colorectal cancer phase 3 study
Sep 25, 2024 8:35am
ESMO: Cancer vaccine and Keytruda deliver in phase 2 trial
Sep 14, 2024 2:30am
Merck stops phase 3 TIGIT trial in lung cancer for futility
Aug 8, 2024 7:49am
Immutep regains pep as cancer subgroup data show path forward
Jul 12, 2024 9:35am
Roche stops pivotal TIGIT trial as Keytruda lands knockout blow
Jul 4, 2024 5:10am
